How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

431 results for

Saint Louis University Mental Status

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Routine Chest Radiography

and increased prevalence of pulmonary disease in a background population. A number of reports have also emphasized the greater likelihood of an abnormal chest radiograph in patients of advanced age [3,8,10,12-14] and a greater risk of major postoperative pulmonary 1 Principal Author, Mayo Clinic, Jacksonville, Florida. 2 Panel Vice-chair, National Jewish Health, Denver, Colorado. 3 Washington University School of Medicine, Saint Louis, Missouri, Society of Thoracic Surgeons. 4 Indiana University (...) years) with altered mental status. There was a small impact on patient care from routine admission chest radiographs, including if obtained on patients with preexisting but stable cardiopulmonary disease. Admission chest radiographs were recommended only on patients with clinical findings of cardiopulmonary disease or elderly patients unable to provide an accurate history or undergo a reliable physical examination. Routine Chest Radiographs in Asymptomatic Outpatients Outpatient chest radiographs

2015 American College of Radiology

62. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

(ITECH, Malawi), Quarraisha Abdool Karim (CAPRISA, South Africa), Nagalingeswaran Kumarasamy (YRGCARE, Medical Centre, India), Karine Lacombe (Saint Antoine Hospital, Paris, France), Loyce Maturu (Africaid, Zimbabwe), Dorothy Mbori-Ngacha (UNICEF, South Africa), Lynne Mofenson (Elizabeth Glaser Pediatric AIDS Foundation, USA), Angela Mushavi (Ministry of Health and Child Care, Zimbabwe), Landon Myer (University of Cape Town, South Africa), Angelina Namiba (Positively UK, United Kingdom), Shinichi Oka (...) of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed

2015 World Health Organisation HIV Guidelines

64. Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)

, 06100 Contact: Renaud David 04.92.03.47.70 APHP Hôpital Broca Not yet recruiting Paris, France, 75013 Contact: Olivier HANON 01.44.08.35.03 Hôpital Universitaire de la Pitié Salpêtrière Pavillon François Lhermitte Not yet recruiting Paris, France, 75013 Contact: Stéphane EPELBAUM 01.42.16.75.22 APHP Groupe Hospitalier Saint Louis Lariboisière Fernand Widal CMRR Not yet recruiting Paris, France, 75475 Contact: Claire PAQUET 01.40.05.49.54 CHU La Milétrie Pôle de Gériatrie Not yet recruiting Poitiers (...) . Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03454646 Recruitment Status : Not yet recruiting First Posted : March 6, 2018 Last Update Posted

2018 Clinical Trials

65. Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome

this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03419156 Locations Layout table for location information United States, Missouri Cardinal Glennon Children's Medical Center Saint Louis, Missouri, United States, 63104 Sponsors and Collaborators St. Louis University Epharmix, Inc. Investigators Layout table for investigator information Principal (...) Last Update Posted : February 18, 2019 Sponsor: St. Louis University Collaborator: Epharmix, Inc. Information provided by (Responsible Party): Yosef Greenspon, MD, St. Louis University Study Details Study Description Go to Brief Summary: The investigators will be using a text messaging intervention to identify potentially dangerous and re- admission causing symptoms in patients with Short Bowel Syndrome (SBS) on Total Parenteral Nutrition (TPN). Each consented patient will receive weekly text

2018 Clinical Trials

66. Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

University Hospital Nice Recruiting Nice, France, 06000 Contact: Christine CHIAVERINI, MD Saint-Louis Hospital - APHP Recruiting Paris, France, 75000 Contact: Emmanuel Bourrat, MD Hôpital Larrey - CHU Toulouse Recruiting Toulouse, France, 31059 Contact: Juliette Mazereeuw-Hautier, Pr Sponsors and Collaborators University Hospital, Toulouse Investigators Layout table for investigator information Principal Investigator: Juliette Mazereeuw-Hautier, MD University Hospital, Toulouse More Information Go (...) studies before adding more. Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex (EBTox) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03453632 Recruitment Status : Recruiting First

2018 Clinical Trials

67. Dissemination and Implementation of Function Focused Care for Assisted Living

[ Time Frame: baseline ] Actigraphy collected for a 5 day period with three full days of data used Function Focused Care Behavioral Checklist for Residents [ Time Frame: baseline ] a 19-item measure that addresses performance by the resident of function focused care Other Outcome Measures: The Saint Louis University Mental Status Examination (SLUMS) [ Time Frame: baseline ] a measure of cognitive ability Eligibility Criteria Go to Information from the National Library of Medicine Choosing (...) . Dissemination and Implementation of Function Focused Care for Assisted Living The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03459118 Recruitment Status : Recruiting First Posted : March 8, 2018 Last Update Posted : March 12

2018 Clinical Trials

68. The Effect of a 30-day Automated Text Messaging Intervention on Hospital Based Acute Care Encounters Following Ileostomy

. ClinicalTrials.gov Identifier: NCT03424954 Recruitment Status : Recruiting First Posted : February 7, 2018 Last Update Posted : February 21, 2019 See Sponsor: St. Louis University Collaborator: Epharmix, Inc. Information provided by (Responsible Party): Grace Montenegro, MD, St. Louis University Study Details Study Description Go to Brief Summary: Each year a large number of patients undergo ileostomy surgery, a procedure in which a portion of the small intestine is attached to a hole in the abdominal wall (...) 30-days following discharge. Additionally, the final message of the automated text-message intervention asks patients if they required readmission or ED care at any non-Saint Louis University Hospital facility(s). Secondary Outcome Measures : Patient response rates [ Time Frame: throughout the 30 days of the intervention ] Automated message response data Patient satisfaction survey results [ Time Frame: One time, on day 30 of the intervention. ] Results of a patient survey administered via

2018 Clinical Trials

69. A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries

(NCT number): NCT03422211 Locations Layout table for location information United States, Missouri Cardinal Glennon Saint Louis, Missouri, United States, 63104 Anheuser Busch Institute Saint Louis, Missouri, United States, 63110 SSM Health St. Mary's Hospital - St. Louis Saint Louis, Missouri, United States, 63117 Sponsors and Collaborators St. Louis University Investigators Layout table for investigator information Principal Investigator: John M Capelle, MD St. Louis University More Information Go (...) : November 15, 2018 Sponsor: St. Louis University Information provided by (Responsible Party): John Capelle, MD, St. Louis University Study Details Study Description Go to Brief Summary: There was a study titled "A prospective evaluation of opioid utilization after upper extremity surgical procedures: Identifying consumption patterns and determining prescribing guidelines" by Dr. Matzon and team from Thomas Jefferson University that came up with a simple set of opioid guidelines post-surgically

2018 Clinical Trials

70. Digital Reminiscence for People With Dementia

by adherence rate (number of sessions completed) Study attrition [ Time Frame: 3 months ] Assessed by % lost to attrition Explore whether outcome measures are sensitive to change - for memory [ Time Frame: 3 months ] Pre-post changes in Arabic Version of Saint-Louis-University-Mental-Status (SLUMS; Abdelrahman & El Gaafary, 2014) it is a 30-point, 11 questions. The maximum score is 30 points. Cut-off scores based on high School Education: 21-26 = Mild Neurocognitive Impairment, 1-20 = Dementia. Less than (...) and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03429686 Recruitment Status : Completed First Posted : February 12, 2018 Last Update Posted : May 2, 2018 Sponsor: University of Nottingham Information provided by (Responsible Party): Holly Blake, University of Nottingham Study Details Study Description Go to Brief

2018 Clinical Trials

71. A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

, California, United States, 90502 United States, Florida Research Site Recruiting Lauderhill, Florida, United States, 33319 United States, Missouri Research Site Recruiting Saint Louis, Missouri, United States, 63141 United States, New Jersey Research Site Recruiting Berlin, New Jersey, United States, 08009 United States, New York Research Site Recruiting Buffalo, New York, United States, 104051 Research Site Recruiting Cedarhurst, New York, United States, 11516 Research Site Recruiting Rochester, New (...) participating. Read our for details. ClinicalTrials.gov Identifier: NCT03745820 Recruitment Status : Recruiting First Posted : November 19, 2018 Last Update Posted : March 15, 2019 See Sponsor: Biogen Information provided by (Responsible Party): Biogen Study Details Study Description Go to Brief Summary: The primary objective of the study is to evaluate the efficacy of BIIB104 in participants with CIAS, using the Working Memory Domain of the MATRICS Consensus Cognitive Battery (MCCB). The secondary

2018 Clinical Trials

72. iTBS Study for Depression (Randomized)

, Missouri Washington University in St. Louis School of Medicine - Healthy Mind Lab Recruiting Saint Louis, Missouri, United States, 63110 Contact: Pilar Cristancho, MD 314-362-2413 Contact: Manuela Araque, BA 314-747-1431 Principal Investigator: Pilar Cristancho, MD Sponsors and Collaborators Washington University School of Medicine More Information Go to Layout table for additonal information Responsible Party: Washington University School of Medicine ClinicalTrials.gov Identifier: Other Study ID (...) of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03745768 Recruitment Status : Recruiting First Posted : November 19, 2018 Last Update Posted : November 22, 2018 See Sponsor: Washington University School of Medicine Information provided by (Responsible Party

2018 Clinical Trials

73. Repetitive TMS & Cognitive Training in Adults With Schizophrenia

-362-5154 Locations Layout table for location information United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rita Haddad, MD 314-362-5154 Contact: Julia Schweiger, CCRC (314) 352-5154 Sponsors and Collaborators Washington University School of Medicine More Information Go to Publications: Layout table for additonal information Responsible Party: Ginger E Nicol, Associate professor of psychiatry, Washington University (...) : No Product Manufactured in and Exported from the U.S.: Yes Keywords provided by Ginger E Nicol, Washington University School of Medicine: cognition schizophrenia schizoaffective disorder Additional relevant MeSH terms: Layout table for MeSH terms Schizophrenia Cognitive Dysfunction Psychotic Disorders Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders Cognition Disorders Neurocognitive Disorders

2018 Clinical Trials

74. Nitrous Oxide- Suicidal Ideation

and Statistical Manual of Mental Disorders (DSM-IV) DSM-IV determined by clinical interview and by a baseline score of ≥18 on the HDRS-21 (Hamilton Depression Rating Scale 21-item; moderate to severe SI defined as a score ≥3 on the HDRS-21 suicide item (item #3); will have good command of the English language; will have been voluntarily admitted to the inpatient Psychiatric Units at Barnes-Jewish Hospital/Washington University in St. Louis, MO. Exclusion Criteria: Lifetime DSM-IV (obtained via MINI) diagnoses (...) to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03736538 Locations Layout table for location information United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Sponsors and Collaborators Washington University School of Medicine

2018 Clinical Trials

75. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. (PubMed)

Louis University Mental Status Exam (SLUMS); and Texas Assessment of Processing Speed (TAPS). In addition, physical performance was measured by handgrip strength and 40-foot timed walks. Lastly, changes in general parameters of healthy immune aging, including serum pro-inflammatory cytokine levels and blood cell subsets, were assessed. Five subjects reported potential adverse side effects; in the RAPA group, these were limited to facial rash (1 subject), stomatitis (1 subject) and gastrointestinal (...) completed at least 8 weeks of treatment and were included in the analysis. We monitored for changes that would indicate detrimental effects of RAPA treatment on metabolism, including both standard clinical laboratory assays (CBC, CMP, HbA1c) and oral glucose tolerance tests (OGTTs). We also monitored parameters typically associated with aging that could potentially be modified by RAPA; these included cognitive function which was assessed by three different tools: Executive Interview-25 (EXIT25); Saint

2018 Experimental Gerontology

76. Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

identifier (NCT number): NCT03755414 Contacts Layout table for location contacts Contact: Mark A Schroeder, M.D. 314-454-8304 Locations Layout table for location information United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Sponsors and Collaborators Washington University School of Medicine Incyte Corporation Investigators Layout table for investigator information Principal Investigator: Mark A Schroeder, M.D. Washington University School (...) and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03755414 Recruitment Status : Not yet recruiting First Posted : November 28, 2018 Last Update Posted : November 29, 2018 See Sponsor: Washington University School of Medicine Collaborator: Incyte Corporation Information provided by (Responsible Party): Washington University

2018 Clinical Trials

77. North American Prodromal Synucleinopathy Consortium

Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jennifer McLeland 314-747-6124 Principal Investigator: Yo-El Ju, MD Canada, Quebec McGill University Not yet recruiting Montréal, Quebec, Canada, HGH 2R9 Contact: Amelie Pelletier 514-934-1934 ext 45462 Principal Investigator: Ronald Postuma, MD Sponsors and Collaborators Washington University School of Medicine Mayo Clinic University of Minnesota - Clinical and Translational Science Institute University of California (...) (NAPS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03623672 Recruitment Status : Recruiting First Posted : August 9, 2018 Last Update Posted : August 31, 2018 See Sponsor: Washington University School of Medicine

2018 Clinical Trials

78. Creating Physical Objects With 3D Printers to Stimulate Reminiscing for Memory Loss [2 R44 AG049548-02A1]

: Will be administered at Week 0 (prior to first therapy session) to establish a baseline. Measures at Week 8 (midpoint of therapy sessions), and Week 16 (following last therapy session) will determine change from the baseline. ] The primary measure of dementia severity will be the Saint Louis University Mental Status (SLUMS) (Tariq, Tumosa, Chibnall, Perry, 2006). The SLUMS has 11 items, the scores on which are summed together to produce a total score. The maximum possible score is 30. Normal range for high school (...) using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: Child, Adult, Older Adult Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: English speaking Physician diagnosis of early-stage Alzheimer's disease or mild cognitive impairment Score of 10 or above on the brief St. Louis University Mental Status examination (SLUMS). Exclusion Criteria: Contacts and Locations Go to Information from

2018 Clinical Trials

79. Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

-5757 Principal Investigator: Kerri Louise Wilks, MD Innovative Clinical Research Inc Recruiting Hialeah, Florida, United States, 33012 Contact: Nestor Morillo 786-454-2950 Principal Investigator: Rishi Kakar, MD Research Centers of America Recruiting Hollywood, Florida, United States, 33024 Contact: Peter Ventre, MD 954-990-7649 ext 111 Principal Investigator: Peter Ventre, MD United States, Missouri St. Louis Clinical Trials Recruiting Saint Louis, Missouri, United States, 63141 Contact: Anthony (...) before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03606395 Recruitment Status : Recruiting First Posted : July 30, 2018 Last Update Posted : February 21, 2019 See Sponsor: Navitor Pharmaceuticals, Inc. Information provided by (Responsible Party): Navitor Pharmaceuticals, Inc. Study Details Study Description Go to Brief Summary: Randomized, two-part, placebo-controlled study of single ascending doses of NV-5138 in healthy volunteers, and a single dose of NV-5138 in subjects

2018 Clinical Trials

80. Role of the Gut Microbiome in Complex Regional Pain Syndrome

of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03612193 Contacts Layout table for location contacts Contact: Lara Crock, MD PhD 314-546-3882 Locations Layout table for location information United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact (...) in Complex Regional Pain Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03612193 Recruitment Status : Recruiting First Posted : August 2, 2018 Last Update Posted : January 30, 2019 See Sponsor: Washington University

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>